Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 17

Results For "inter"

3453 News Found

Shreevar Kheruka appointed Managing Director at Borosil Limited
People | May 23, 2026

Shreevar Kheruka appointed Managing Director at Borosil Limited

Kheruka has played a key role in transforming Borosil into a diversified, international consumer-focused enterprise


Maxivision appoints Surya K as Group Head – Medical Affairs and Quality
People | May 23, 2026

Maxivision appoints Surya K as Group Head – Medical Affairs and Quality

Surya to lead medical governance, patient safety, clinical excellence, and quality assurance initiatives across the organization’s pan-India network.


Fortis Healthcare  FY26 revenue crosses Rs. 9,100 crore
Hospitals | May 23, 2026

Fortis Healthcare FY26 revenue crosses Rs. 9,100 crore

Q4 FY26 PAT jumps 44% to Rs. 271 crore, supported by acquisitions, specialty expansion, and diagnostics momentum


Health ministry classifies Pregabalin under Schedule H1 to curb misuse
Policy | May 23, 2026

Health ministry classifies Pregabalin under Schedule H1 to curb misuse

New regulation mandates stricter prescription monitoring, sales record maintenance, and enhanced compliance across the pharmaceutical supply chain


Gujarat Themis Biosyn acquires MicroBiopharm Japan for Rs. 1,300 Cr
News | May 23, 2026

Gujarat Themis Biosyn acquires MicroBiopharm Japan for Rs. 1,300 Cr

Transition to a fermentation-based globally integrated CDMO platform


OncoSil secures TGA approval for pancreatic cancer device
News | May 22, 2026

OncoSil secures TGA approval for pancreatic cancer device

Approval of device in Australia for treating locally advanced pancreatic cancer alongside gemcitabine-based chemotherapy


Reliance Life Sciences appoints Siva Sankar Mahamkali as VP Biosimilars Manufacturing Operations
People | May 22, 2026

Reliance Life Sciences appoints Siva Sankar Mahamkali as VP Biosimilars Manufacturing Operations

Biologics manufacturing veteran brings over two decades of expertise in biosimilars, GMP operations, and large-scale biopharmaceutical manufacturing


Multimodal AI emerges as next leap in predictive healthcare: Ashwattha Sahasrabuddhe, Principal Architect and Technology & Practice Head – Healthcare Business, Tata Elxsi
Opinion | May 22, 2026

Multimodal AI emerges as next leap in predictive healthcare: Ashwattha Sahasrabuddhe, Principal Architect and Technology & Practice Head – Healthcare Business, Tata Elxsi

Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond


Venus Remedies secures global approval for Plerixafor in Saudi Arabia
Drug Approval | May 22, 2026

Venus Remedies secures global approval for Plerixafor in Saudi Arabia

SFDA nod marks company’s strategic entry into high-value specialty oncology injectables as it targets expanding stem cell transplant and haemato-oncology market in the GCC region


Jubilant Pharmova posts 14% FY26 revenue growth to Rs. 8,280 crore amid margin pressure
News | May 22, 2026

Jubilant Pharmova posts 14% FY26 revenue growth to Rs. 8,280 crore amid margin pressure

Q4FY26 revenue climbs 19% to Rs. 2,290 crore as CDMO sterile injectables, radiopharma and generics businesses drive growth momentum